EUCRATES BIOMEDICAL ACQU COR - UNIT 10/23/2027 (EUCRU)

CUSIP: G3141W114

Q1 2023 13F Holders as of 31 Mar 2023

Type / Class
Equity / UNIT 10/23/2027
Total 13F shares
649,018
Share change
-2,935
Total reported value
$6,722,364
Price per share
$10.36
Number of holders
4
Value change
-$29,196
Number of buys
1
Number of sells
2

Quarterly Holders Quick Answers

What is CUSIP G3141W114?
CUSIP G3141W114 identifies EUCRU - EUCRATES BIOMEDICAL ACQU COR - UNIT 10/23/2027 in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of EUCRATES BIOMEDICAL ACQU COR - UNIT 10/23/2027 (EUCRU) as of Q1 2023

As of 31 Mar 2023, EUCRATES BIOMEDICAL ACQU COR - UNIT 10/23/2027 (EUCRU) was held by 4 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 649,018 shares. The largest 4 holders included Verition Fund Management LLC, Sio Capital Management, LLC, CLEAR STREET LLC, and DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C). This page lists 4 institutional shareholders reporting positions in this security for the Q1 2023 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.